Bank of Montreal’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-500,000
Closed -$5.3K 4046
2022
Q3
$5.3K Hold
500,000
﹤0.01% 1323
2022
Q2
$6.32K Hold
500,000
﹤0.01% 1293
2022
Q1
$5.5M Buy
+500,000
New +$6.07M ﹤0.01% 1439
2021
Q4
Sell
-300
Closed -$6K 3579
2021
Q3
$6K Buy
+300
New +$3.98K ﹤0.01% 3738
2019
Q2
Sell
-100,000
Closed -$731K 4896
2019
Q1
$731K Hold
100,000
﹤0.01% 2143
2018
Q4
$915K Buy
+100,000
New +$1.11M ﹤0.01% 1929

Other funds holding DVAX

Bank of Montreal's DVAX Position: Q1 2026 in Review

Bank of Montreal sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 265,423 shares — an estimated $4.08M sold.

Bank of Montreal first reported a position in DVAX in Q2 2013 and held it in 50 quarters. The position peaked at $23M in Q4 2021. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Bank of Montreal reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Bank of Montreal sold 265,423 Dynavax Technologies shares in Q1 2026, an estimated $4.08M.
  • Bank of Montreal first reported a position in Dynavax Technologies in Q2 2013 and held it in 50 quarters.
  • Bank of Montreal's Dynavax Technologies position peaked at $23M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.